Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-92,277
Closed -$3.37M 270
2015
Q4
$3.37M Sell
92,277
-162,817
-64% -$6.22M 0.25% 87
2015
Q3
$9.21M Sell
255,094
-110,860
-30% -$4.26M 0.25% 99
2015
Q2
$14.7M Sell
365,954
-24,024
-6% -$1.04M 0.25% 101
2015
Q1
$16.8M Sell
389,978
-9,261
-2% -$401K 0.28% 83
2014
Q4
$18M Sell
399,239
-7,353
-2% -$299K 0.3% 78
2014
Q3
$15.6M Sell
406,592
-4,240
-1% -$172K 0.28% 86
2014
Q2
$16.7M Buy
410,832
+2,350
+0.6% +$96.7K 0.29% 80
2014
Q1
$16.7M Sell
408,482
-30,166
-7% -$1.15M 0.3% 68
2013
Q4
$16.8M Buy
438,648
+10,069
+2% +$346K 0.3% 67
2013
Q3
$14.2M Buy
428,579
+6,156
+1% +$200K 0.25% 72
2013
Q2
$13M Buy
+422,423
New +$14M 0.24% 73

Other funds holding ORCL

Curian Capital's ORCL Position: Q1 2016 in Review

Curian Capital sold out of Oracle (ORCL) in Q1 2016, closing a stake of 92,277 shares — an estimated $3.37M sold.

Curian Capital first reported a position in ORCL in Q2 2013 and held it in 11 quarters. The position peaked at $18M in Q4 2014. 1,521 funds tracked by Wall St. Rank hold ORCL as of Q1 2016.

  • Curian Capital reported no remaining Oracle position as of Q1 2016 after selling out during the quarter.
  • Curian Capital sold 92,277 Oracle shares in Q1 2016, an estimated $3.37M.
  • Curian Capital first reported a position in Oracle in Q2 2013 and held it in 11 quarters.
  • Curian Capital's Oracle position peaked at $18M in Q4 2014.
  • 1,521 funds tracked by Wall St. Rank held Oracle as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.